Alphabet’s biolab in funding talks at $40B valuation

T1Covered by 1 source · first reported by Semafor (filter tech) at 08 Oct, 11:08 UTC

The company hopes the new investment will accelerate its push to develop new drugs.

business

Sources

• T1Alphabet’s biolab in funding talks at $40B valuationSemafor (filter tech)08 Oct, 11:08